Clinical significance of the immunohistochemical profile of ovarian endometrioid cysts

Tezikov Yu.V., Strizhakov A.N., Lipatov I.S., Kalinkina O.B., Aravina O.R., Martynova N.V.

1) Samara State Medical University, Ministry of Health of Russia, Samara, Russia; 2) I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia, Moscow, Russia
Objective. To identify the immunohistochemical (IHC) phenotypes on the basis of the representation of molecular markers in the endometrioid ovarian cyst (EOC) capsule (EOCC) in order to justify a differentiated approach to therapy and to reduce relapse rates. Subjects and methods. To identify the features of the IHC profile of EOCC (the expression of estrogen and progesterone receptors, Ki-67, p53) and to estimate the impact of personalized anti-relapse therapy after surgical treatment, the investigators examined 170 women with EOC, who formed three comparison groups: 1) 50 women who received anti-relapse treatment with regard to the IHC profile of EOCC; 2) 80 women who had hormone therapy after the surgical stage of treatment without regard to the IHC phenotype; 3) 40 women who refused subsequent hormone therapy after surgical treatment. Control endometrial samples were taken from 25 healthy women. Results. Four IHC phenotypes of EOCC were identified. A differentiated approach to treatment with regard to the type of the IHC profile showed the higher efficiency than hormone therapy without regard to the IHC phenotype: the number needed to treat (NNT) was 2 to prevent an unfavorable outcome in one patient [95% CI, 1-2; p < 0.001] versus NNT of 3 [95% CI, 2-6; p <0.001], OR, 0.06 [95% CI, 0.02-0.25; p <0.001] versus OR, 0.42 [95% CI, 0.27-0.65; p <0.001]. Conclusion. EOCs are characterized by molecular structural and functional heterogeneity, which objectifies IHC analysis of EOCC for the selection of a pathogenetically sound medical therapy regimen.

Keywords

endometrioid ovarian cysts
immunohistochemical analysis
estrogen and progesterone receptors
Ki-67
p53
personalized treatment
relapse rate

References

  1. Dunselman G.A., Vermeulen N., Becker C., Calhaz-Jorge C., D’Hooghe T., De Bie B. et al. ESHRE guideline: management of women with endometriosis. Human reproduction (Oxford, England). 2014; 29(3): 400–12. doi: 10.1093/humrep/det457.
  2. Sanchez A.M ., Viganò P., Somigliana E., Panina-Bordignon P., Vercellini P., Candiani M. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Human Reproduction Update. 2014; 20(2): 217–30. doi: 10.1093/humupd/dmt053.
  3. Goteri G., Altobelli E., Tossetta G., Zizzi A., Avellini C., Licini C. et al. HIHC temperature requirement A1, transforming growth factor beta1, phosphoSmad2 and Ki67 in eutopic and ectopic endometrium of women with endometriosis. European journal of histochemistry: EJH. 2015; 59(4): 2570. doi: 10.4081/ejh.2015.2570.
  4. Шрамко С.В., Баженова Л.Г., Бондарев О.И., Лихачева В.В. Пролиферативные заболевания матки: анамнестические и клинико-морфологические параллели. Российский вестник акушера-гинеколога. 2017; 5: 12–16. [Shramko S.V., Bazhenova L.G., Bondarev O.I., Likhacheva V.V. Proliferative diseases of the uterus: anamnestic and clinical-morphological parallels. Russian Bulletin of the Obstetrician-Gynecologist. 2017; 5: 12–16. (in Russ.)]
  5. Alif M., Anwar R., Pribadi A. Ki-67 Expression is Correlated with Cyst Size and Stage of Endometriosis. Indonesian Journal of Obstetrics and Gynecology. 2013; 1(3): 124–28. doi: 10.1016/s0029-7844(99)00279-3
  6. Пшеничнюк Е.Ю., Асатурова А.В., Адамян Л.В., Зайцев Н.В. Иммуногистохимические особенности эутопического и эктопического эндометрия у пациенток с рецидивирующим течением эндометриоидных кист яичников. Акушерство и гинекология. 2018; 3: 84–95. [Pshenichnyuk E.Yu., Asaturova A.V., Adamyan L.V., Zaitsev N.V. Immunohistochemical features of eutopic and ectopic endometrium in patients with recurrent course of endometrioid ovarian cysts. Akusherstvo i Ginekologiya/Obstetrics and gynecology. 2018; 3: 84–95. (in Russ.)]. doi:10.17116/patol201880414
  7. Brătilă E., Brătilă C.P., Comandaşu D.E., Bauşic V., Vlădescu C.T., Mehedinţu C. et al. The assessment of immunohistochemical profile of endometriosis implants, a practical method to appreciate the aggressiveness and recurrence risk of endometriosis. Romanian journal of morphology and embryology=Revue roumaine de morphologie et embryologie. 2015; 56(4): 1301–307.
  8. Пшеничнюк Е.Ю., Асатурова А.В., Адамян Л.В., Зайцев Н.В. Иммуногистохимические предикторы рецидивирования эндометриоидных кист яичников после лапароскопического оперативного лечения. Архив патологии. 2018; 80(4): 14–20. [Pshenichnyuk E.Yu., Asaturova A.V., Adamyan L.V., Zaitsev N.V. Immunohistochemical predictors of recurrence of endometrioid ovarian cysts after laparoscopic surgical treatment. Archive of Pathology/Arkhiv Patologii. 2018; 80(4): 14–20. (in Russ.)]. doi:10.17116/patol201880414
  9. Калинкина О.Б., Тезиков Ю.В., Тезикова Т.А., Липатов И.С., Крюкова Г.А., Аравина О.Р. Эффективность терапии пациенток с эндометриоидными кистами яичников. Аспирантский вестник Поволжья. 2016; 1-2: 21–6. [Kalinkin O.B., Thesikov Yu.V., Thesikova T.A., Lipatov I.S., Krukova G.A., Aravina O.R. Effectiveness of therapy of patients with endometrioid ovarian cysts. Aspirantskij vestnik Povolzh'ya. 2016; 1-2: 21–6. (in Russ.)].
  10. Адамян Л.В., Андреева Е.Н., Аполихина И.А., Беженарь В.Ф., Геворкян М.А., Гус А.И., Демидов В.Н., Калинина Е.А., Леваков С.А., Марченко Л.А., Попов А.А., Сонова М.М., Хашукоева А.З., Чернуха Е.А., Яроцкая Е.Л. Эндометриоз: диагностика, лечение и реабилитация. Клинические рекомендации по ведению больных. М.; 2013. 90 с. [Adamyan L.V., Andreeva E.N., Apolikhina I.A., Bezhenar V.F., Gevorkyan M.A., Gus A.I., Demidov V.N., Kalinina E.A., Levakov S .A., Marchenko L.A., Popov A.A., Sonova M.M., Khashukoeva A.Z., Chernukha E.A., Yarotskaya E.L. Endometriosis: diagnosis, treatment and rehabilitation. Clinical guidelines for patient management. M.; 2013. 90 p. (in Russ.)].
  11. Kumar G.L., Rudbeck L., ed. Education Guide. Immunohistochemical Staining Methods. DAKO. Carpinteria, 2009. 160 p.
  12. Котельников Г.П., Шпигель А.С. Доказательная медицина. Научно обоснованная медицинская практика: монография. 2-е изд., доп. и перераб. М.: ГЭОТАР-Медиа, 2012. 239 с. [Kotelnikov G.P., Shpigel A.S. Evidence-based medicine. Evidence-based medical practice: monograph. 2 nd ed., updat. and rev. M.: GEOTAR Media, 2012. 239 p. (in Russ.)].
  13. Istrate-Ofiţeru A.M., Pirici D., Niculescu M., Berceanu C., Berceanu S., Voicu N.L. et al. Clinical, morphological and immunohistochemical survey in different types of endometriosis. Rom. J. Morphol. Embryol. 2018; 59(4): 1133–53. PMID: 30845295
  14. Yu X., Ren H., Liu T., Yong M., Zhong H. Expression and significance of ERβ and TrkB in endometriosis. Clin. Exp. Obstet. Gynecol. 2016; 43(1): 75–81.
  15. Khan K.N., Fujishita A., Kitajima M., Hiraki K., Nakashima M., Masuzaki H. Occult microscopic endometriosis: undetectable by laparoscopy in normal peritoneum. 1. Hum Reprod. 2014; 29(3): 462–72. doi: 10.1093/humrep/det438
  16. Nguyen T.T., Hachisuga T., Urabe R., Ueda T., Kurita T., Kagami S. Immunohistochemical Analysis of the Effect of Dienogest on Ovarian Endometriotic Cysts. J UOEH. 2016; 38(4): 271–78. doi: 10.7888/juoeh.38.271

Received 18.10.2019

Accepted 29.11.2019

About the Authors

Yury V. Tezikov, MD, professor, head of obstetrics and gynecology chair number 1 of Federal State Budgetary Educational Institution of Higher Education «Samara State Medical University» of the Ministry of Healthcare of the Russian Federation, e-mail: yra.75@inbox.ru ORCID 0000-0002-8946-501X.
443099, Russia, Samara, ul. Chapaevskaya, d. 89.
Aleksandr N. Strizhakov, MD, professor member of the Russian Academy of Science, honored doctor, head of obstetrics, gynecology and perinatology chair of I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia, Moscow, Russia. 119991, Moscow, st. Trubetskaya, d. 8, p. 2.
Igor S. Lipatov, MD, professor, professor of obstetrics and gynecology chair number 1 of Federal State Budgetary Educational Institution of Higher Education «Samara State Medical University» of the Ministry of Healthcare of the Russian Federation, e-mail:i.lipatoff2012@yandex.ru ORCID 0000-0001-7277-7431
443099, Russia, Samara, ul. Chapaevskaya, d. 89.
Olga B. Kalinkina, MD, professor, professor of obstetrics and gynecology chair number 1 of Federal State Budgetary Educational Institution of Higher Education «Samara State Medical University» of the Ministry of Healthcare of the Russian Federation, е-mail: maiorof@mail.ru ORCID 0000-0002-1828-3008
443099, Russia, Samara, ul. Chapaevskaya, d. 89.
Oksana R. Aravina, teaching assistant of obstetrics and gynecology chair number 1 of Federal State Budgetary Educational Institution of Higher Education «Samara State Medical University» of the Ministry of Healthcare of the Russian Federation, e-mail: dr.aravina@gmail.com ORCID 0000-0002-2107-1508
443099, Russia, Samara, ul. Chapaevskaya, d. 89.
Nadezhda V. Martynova, teaching assistant of obstetrics and gynecology chair number 1 of Federal State Budgetary Educational Institution of Higher Education «Samara State Medical University» of the Ministry of Healthcare of the Russian Federation, e-mail: og1samsmu @mail.ru ORCID 0000-0002-2107-1508
443099, Russia, Samara, ul. Chapaevskaya, d. 89.
Olga B. Kalinkina, MD, professor, professor of obstetrics and gynecology chair number 1 of Samara State Medical University, е-mail: maiorof@mail.ru
ORCID 0000-0002-1828-3008 443099, Russia, Samara, ul. Chapaevskaya, d. 89.
Oksana R. Aravina, teaching assistant of obstetrics and gynecology chair number 1 of Samara State Medical University, e-mail: dr.aravina@gmail.com
ORCID 0000-0002-2107-1508 443099, Russia, Samara, ul. Chapaevskaya, d. 89.
Nadezhda V. Martynova, teaching assistant of obstetrics and gynecology chair number 1 of Samara State Medical University, e-mail: og1samsmu @mail.ru
ORCID 0000-0002-2107-1508 443099, Russia, Samara, ul. Chapaevskaya, d. 89.

For citation: Tezikov Yu.V., Strizhakov A.N., Lipatov I.S., Kalinkina O.B., Aravina O.R., Martynova N.V. Clinical significance of the immunohistochemical profile of ovarian endometrioid cysts.
Akusherstvo i Ginekologiya/ Obstetrics and gynecology. 2020; 2: 116-24.(In Russian).
https://dx.doi.org/10.18565/aig.2020.2.116-124

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.